Hello, folks, and how are you today? Once again, we are off to an early start as we hustle assorted short people off to their local school houses. But we enjoy challenges, including our menu of meetings and deadlines that await. To cope, yes, we are brewing that mandatory cup of stimulation - we are back to Southern Pecan this morning - and invite you to join us. Meanwhile, here are some tidbits to get you going. Hope your day goes well and stay in touch...
Novartis Meningititis B Vaccine Is Highly Effective: Study (The Telegraph)
FDA Rebuffs AstraZeneca, Bristol-Myers Diabetes Drug (Reuters)
Roche Melanoma Drug Spurs Growth Of Other Skin Cancer: Study (Bloomberg News)
Film Producers Option Book On J&J Marketing Of Procrit (Reuters)
Bristol-Myers Hep C Pills Clear Virus Without Interferon (Bloomberg News)
J&J Hid Risperdal Diabetes Study From FDA: Witness (Bloomberg News)
Cipla Tries A Makeover (Economic Times)
Israelis Overpay For OTC Drugs (Globes)
Sandoz Starts Late-Stage Trial Of Two Amgen Drugs (Economic Times)
Liv Tyler To Star In A Pharmaceutical Thriller (Empire)
PBMs Run New Ad Campaign To Explain What They Do (The Hill)
How Lupin Cracked The Japanese Pharma Market (Business Standard)
Novartis Gets OK To Market Lucentis In China (Pharma Times)
EDITOR'S NOTE: Please check this post for updates throughout the morning